ETANERCEPT TREATMENT RESULTS IN CHILDREN WITH NON-SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS: REMISSION, RECRUDESCENCE, AND ADVERSE EVENTS. RETROSPECTIVE COHORT STUDY

ETANERCEPT TREATMENT RESULTS IN CHILDREN WITH NON-SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS: REMISSION, RECRUDESCENCE, AND ADVERSE EVENTS. RETROSPECTIVE COHORT STUDY

Background. Etanercept is a biological drug most commonly used in patients with juvenile idiopathic arthritis (JIA). The results of its use are showed in local studies.Objective. Our aim was to evaluate the efficacy and safety of the use of etanercept in children with non-systemic JIA, to determine...

Full description

Bibliographic Details
Main Authors: Mikhail M. Kostik, Irina A. Chikova, Eugenia A. Isupova, Maria N. Likhacheva, Tatyana S. Likhacheva, Margaruta F. Dubko, Vera V. Masalova, Ludmila S. Snegireva, Ekaterina V. Gaidar, Olga V. Kalashnikova, Vyacheslav G. Chasnyk
Format: Article
Language:English
Published: "Paediatrician" Publishers LLC 2018-05-01
Series:Voprosy Sovremennoj Pediatrii
Subjects:
children
juvenile idiopathic arthritis
etanercept
remission
exacerbations
risk factors
Online Access:https://vsp.spr-journal.ru/jour/article/view/1883

Internet

https://vsp.spr-journal.ru/jour/article/view/1883

Similar Items